Celebrex Growth Is "Typical" Of NSAIDs After Three Years, Pharmacia Says

Pharmacia's Celebrex is showing a growth curve that is typical for products in the non-steroidal anti-inflammatory class, CEO Fred Hassan acknowledged during a July 25 analysts call.